SIMONA CAMPA: Open Payments
NPI 1609350768 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$197 in 9 payments from 5 companies in 2025. Trend: 2023 $334 · 2024 $18 · 2025 $197
Food & beverage: $197
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $59 |
| Boston Scientific Corporation | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
| Novo Nordisk Inc | 1 | $17 |
Products named: REPATHA, General - Pain Management, FARXIGA, JARDIANCE, Wegovy.
Industry payments across TX — which companies pay providers there.
